Regenicin, Inc. (RGIN)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 9, 2025
Regenicin Company Description
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes.
Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers.
The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures.
The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010.
Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
Regenicin, Inc.
| Country | United States |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Randall McCoy |
Contact Details
Address: 10 High Court Little Falls, Wyoming 07424 United States | |
| Phone | 973 557 8914 |
| Website | regenicin.com |
Stock Details
| Ticker Symbol | RGIN |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| ISIN Number | US75887Q1022 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Randall E. McCoy | Chairman, Chief Executive Officer and President |
| John J. Weber | Chief Financial Officer and Director |
| Dr. J. Roy Nelson Ph.D. | Controller and Chief Science Officer |